The University of California, San Francisco is part of the University of California system and is a major center of medical and biological research and teaching.
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.